When BCBS covers GLP-1 medications for weight loss, typical PA requirements include: BMI 30+ or 27+ with a comorbidity (hypertension, type 2 diabetes, high cholesterol), 3-6 months of documented lifestyle modification , and sometimes step therapy
Important Safety Warnings Seek immediate medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Signs of dehydration from vomiting or diarrhea (dizziness, decreased urination, extreme thirst) Symptoms of gallbladder disease (right upper quadrant pain, fever, yellowing of skin or eyes) Severe hypoglycemia (confusion, loss of consciousness, seizures) Allergic reactions (difficulty breathing, swelling of face or throat, severe rash) Vision changes (if diabetic) Rapid or irregular heartbeat with chest discomfort Do not use semaglutide if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known hypersensitivity to semaglutide or any formulation components Pregnancy or plans to become pregnant (discontinue at least 2 months before conception) Use with caution if you have: History of pancreatitis, severe gastrointestinal disease, diabetic retinopathy, kidney disease, or are taking insulin or sulfonylureas
The MCCM Medical Glutathione peel can be applied to the darkest parts of the body
People who should not use GLP-1s include: Pregnant people People with a personal or family history of medullary thyroid cancer People with multiple endocrine neoplasia syndrome type 2, a rare condition that affects the endocrine glands People who are hypersensitive to GLP-1 agonist drugs GLP-1 Drugs Are Lifelong Treatments Questions to Ask Your Doctor Am I a candidate for a GLP-1 weight loss drug
Because of the high heterogeneity of RA, researchers realize that the current efforts are far from enough to recommend specific DMARDs for individual patients
